Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis

This publication has 27 references indexed in Scilit:

• Chromosomal Microarray versus Karyotyping for Prenatal Diagnosis
  New England Journal of Medicine, 2012
• The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy
  The Journal of Maternal-Fetal & Neonatal Medicine, 2012
• Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA Sequencing
  Obstetrics & Gynecology, 2012
• DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study
  Genetics in Medicine, 2012
• Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting
  American Journal of Obstetrics and Gynecology, 2011
• Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study
  BMJ, 2011
• A reassessment of biochemical marker distributions in trisomy 21‐affected and unaffected twin pregnancies in the first trimester
  Ultrasound in Obstetrics & Gynecology, 2010
• First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers
  Prenatal Diagnosis, 2010
• Role of Second-Trimester Genetic Sonography After Down Syndrome Screening
  Obstetrics & Gynecology, 2009
• Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11–14‐week scan
  Ultrasound in Obstetrics & Gynecology, 2004